Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in meta...
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study
About this item
Full title
Author / Creator
LORUSSO, V , GIOTTA, F , BORDONARO, R , MAIELLO, E , DEL PRETE, S , GEBBIA, V , FILIPELLI, G , PISCONTI, S , CINIERI, S , ROMITO, S , RICCARDI, F , FORCIGNANÒ, R , CICCARESE, M , PETRUCELLI, L , SARACINO, V , LUPO, L.I , GAMBINO, A , LEO, S and COLUCCI, G
Publisher
Athens: D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
Athens: D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
We conducted a phase III multicenter randomized trial to compare the efficacy of the combination of liposome encapsulated doxorubicin (Myocet©) plus either cyclophosphamide (MC) or vinorelbine (MV). Since July 2006, 233 patients affected with metastatic breast cancer were randomized to receive the combination of Myocet (M) 60 mg/m2 i.v. plus cyclop...
Alternative Titles
Full title
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1932334091
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1932334091
Other Identifiers
ISSN
1019-6439
E-ISSN
1791-2423
DOI
10.3892/ijo.2014.2604